MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board Post published:March 29, 2021 Post category:Press Release
Horizons ETFs Completes Rebalance of World’s First Psychedelics ETF Post published:March 27, 2021 Post category:Press Release
Champignon Brands Announces Filing of Listing Statement Post published:March 26, 2021 Post category:Press Release
Psychedelic Bulletin: UW-Madison Launches Psychedelic Master’s Program; COMPASS Granted 2 Patents Post published:March 26, 2021 Post category:Psychedelic Bulletin
Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness Post published:March 25, 2021 Post category:Press Release
Psygen Industries Ltd. and Larose Ventures Ltd. Announce Reverse Takeover Transaction of 1290442 B.C. Ltd. by Psygen Industries Ltd. and Brokered Financing Led by Eight Capital and Canaccord Post published:March 24, 2021 Post category:Press Release
Psilocybin Data Study Agreement Reached Between Silo Wellness and Ehave Using Brain Scientific Mapping Neurocap Post published:March 24, 2021 Post category:Press Release
Numinus Deep Dive: Developing and Delivering Psychedelic-Assisted Psychotherapies Post published:March 23, 2021 Post category:Analysis/Editorial
Mindset Pharma and InterVivo Solutions to Jointly Develop Advanced Cooperative Psychedelics Evaluation Platform (“Cope”); Cope Expected to Be World’s First in Vivo Psychedelic Benchmark Data Set Post published:March 23, 2021 Post category:Press Release